Andere talen Zhejiang Orient Gene Biotech Co.,Ltd

Aandelen

688298

CNE100003RM8

slotkoers Shanghai S.E. Andere beurzen 00:00:00 02-07-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
25,9 ^CNY	-1,33%		-2,67%	-27,57%

29/04	Zhejiang Orient Gene Biotech Co.,Ltd rapporteert resultaten voor het eerste kwartaal eindigend op 31 maart 2024	CI
28/02	Zhejiang Orient Gene Biotech Co.,Ltd rapporteert resultaten voor het volledige jaar eindigend op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

US FDA Grants Emergency Use Authorization to Orient Gene Biotech's COVID-19 Test Kit	12/06
Orient Gene Biotech's US Unit Gets FDA Clearance for Fentanyl Detectors	16/05
Zhejiang Orient Gene Biotech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04
Zhejiang Orient Gene Biotech's Unit Gets US FDA's Nod to Register Two Products	23/04
Zhejiang Orient Gene Biotech Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	28/02
Zhejiang Orient Gene Biotech Co.,Ltd announces an Equity Buyback for CNY 100 million worth of its shares.	08/02
Zhejiang Orient Gene Biotech Co.,Ltd authorizes a Buyback Plan.	07/02
Zhejiang Orient Gene Obtains Veterinary GMP Certificate, Production License	08/01
Zhejiang Orient Gene Biotech Co.,Ltd(SHSE:688298) dropped from Shanghai Stock Exchange Health Care Sector Index	08/12
Zhejiang Orient Gene Biotech Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	30-10-23
Zhejiang Orient Gene Biotech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	29-08-23
Orient Gene Biotech Registers New In Vitro Diagnostic Reagents	13-07-23
Zhejiang Orient Gene Biotech Elects Chairman, Vice Chairman	01-06-23
Zhejiang Orient Gene Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	27-04-23
Zhejiang Orient Gene Registers Two Medical Devices in EU, US	24-03-23
Zhejiang Orient Gene Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	27-02-23
IN BRIEF: Omega Diagnostics receives CD4 deferred consideration	25-11-22
Zhejiang Orient Gene Biotech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	30-10-22
Zhejiang Orient Gene Biotech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	29-08-22
Omega Diagnostics Up 16% With Sale Of Loss-Making CD4 Business	03-08-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Zhejiang Orient Gene Biotech Co.,Ltd

Aandelen

688298

CNE100003RM8

Andere talen

Filters